 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1fpr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.3.48
- Protein-tyrosine-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Protein tyrosine phosphate + H2O = protein tyrosine + phosphate
|
 |
 |
 |
 |
 |
Protein tyrosine phosphate
Bound ligand (Het Group name = )
matches with 76.00% similarity
|
+
|
H(2)O
|
=
|
protein tyrosine
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
dephosphorylation
|
2 terms
|
 |
|
Biochemical function
|
phosphatase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
275:4066-4071
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1.
|
|
J.Yang,
Z.Cheng,
T.Niu,
X.Liang,
Z.J.Zhao,
G.W.Zhou.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The substrate specificity of the catalytic domain of SHP-1, an important
regulator in the proliferation and development of hematopoietic cells, is
critical for understanding the physiological functions of SHP-1. Here we report
the crystal structures of the catalytic domain of SHP-1 complexed with two
peptide substrates derived from SIRPalpha, a member of the signal-regulatory
proteins. We show that the variable beta5-loop-beta6 motif confers SHP-1
substrate specificity at the P-4 and further N-terminal subpockets. We also
observe a novel residue shift at P-2, the highly conserved subpocket in protein-
tyrosine phosphatases. Our observations provide new insight into the substrate
specificity of SHP-1.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. A and B, the electron density maps (2F[o] F[c]) for
the phosphotyrosyl peptide sites in both Tyr(P)469 (A) and
Tyr(P)495 (B) complexes. The maps are contoured at 1.0 to 2.5 (A)
and 2.3 Å (B), respectively, with the refined models of
the decapeptides in yellow. The amino acids are labeled. C and
D, ribbon representations of the Tyr(P)469 (C) and the Tyr(P)495
(D) complex structures. The peptides are shown in the stick
model. The catalytic domain of SHP-1 is shown in green.
Structures of the catalytic domain in the two complexes were
almost identical, with an r.m.s deviation of 0.5 Å. They
were also similar to the native catalytic domain structure (7),
with an r.m.s deviation of 0.8 Å. This Fig. was prepared
by SETOR (25). E, comparison of peptides Tyr(P)469 and Tyr(P)495
after superimposing two complexes on their catalytic domains.
Peptides Tyr(P)469 and Tyr(P)495 are shown in yellow and blue,
respectively.
|
 |
Figure 3.
Fig. 3. Superimposition of the Tyr(P)469 and Tyr(P)495
complex structures with the PTP1B-hexapeptide complex structure.
The peptides are shown as stick models, and the catalytic
domains are shown as ribbons. The Tyr(P)469, Tyr(P)495, and
PTP1B complex structures are shown in yellow, blue, and gray,
respectively. The only similarity between the SHP-1-peptide
complex structures and PTP1B-hexapeptide structure was that
residue Tyr(P) fit into the Tyr(P)-binding subpocket, and the
phosphate group of residue Tyr(P) made extensive hydrogen bonds
with the PTP signature motif. In the PTP1B-hexapeptide
structure, the side chain of residue Leu P+1 pointed in the
direction of the main chain of peptides Tyr(P)469 and Tyr(P)495
in the SHP-1 complex structures. This directional change may
have been caused by the end effects (i.e. LeuP+1 is the
C-terminal residue). However, at the N terminus the peptide was
positioned away from the PTP1B molecule and extended into the
solvent.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2000,
275,
4066-4071)
copyright 2000.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Liu,
Z.Yu,
X.Yu,
S.X.Huang,
Y.Luo,
L.Wu,
W.Shen,
Z.Yang,
L.Wang,
A.M.Gunawan,
R.J.Chan,
B.Shen,
and
Z.Y.Zhang
(2011).
SHP2 is a target of the immunosuppressant tautomycetin.
|
| |
Chem Biol, 18,
101-110.
|
 |
|
|
|
|
 |
L.Gao,
H.Sun,
and
S.Q.Yao
(2010).
Activity-based high-throughput determination of PTPs substrate specificity using a phosphopeptide microarray.
|
| |
Biopolymers, 94,
810-819.
|
 |
|
|
|
|
 |
X.Zhang,
Y.He,
S.Liu,
Z.Yu,
Z.X.Jiang,
Z.Yang,
Y.Dong,
S.C.Nabinger,
L.Wu,
A.M.Gunawan,
L.Wang,
R.J.Chan,
and
Z.Y.Zhang
(2010).
Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).
|
| |
J Med Chem, 53,
2482-2493.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.A.Critton,
A.Tortajada,
G.Stetson,
W.Peti,
and
R.Page
(2008).
Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.
|
| |
Biochemistry, 47,
13336-13345.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Tabernero,
A.R.Aricescu,
E.Y.Jones,
and
S.E.Szedlacsek
(2008).
Protein tyrosine phosphatases: structure-function relationships.
|
| |
FEBS J, 275,
867-882.
|
 |
|
|
|
|
 |
W.M.Yu,
O.Guvench,
A.D.Mackerell,
and
C.K.Qu
(2008).
Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay.
|
| |
J Med Chem, 51,
7396-7404.
|
 |
|
|
|
|
 |
A.S.Wavreille,
M.Garaud,
Y.Zhang,
and
D.Pei
(2007).
Defining SH2 domain and PTP specificity by screening combinatorial peptide libraries.
|
| |
Methods, 42,
207-219.
|
 |
|
|
|
|
 |
J.A.Ubersax,
and
J.E.Ferrell
(2007).
Mechanisms of specificity in protein phosphorylation.
|
| |
Nat Rev Mol Cell Biol, 8,
530-541.
|
 |
|
|
|
|
 |
S.Li,
R.S.Depetris,
D.Barford,
J.Chernoff,
and
S.R.Hubbard
(2005).
Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.
|
| |
Structure, 13,
1643-1651.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.H.Lee,
A.Raas-Rotschild,
M.A.Miteva,
G.Bolasco,
A.Rein,
D.Gillis,
D.Vidaud,
M.Vidaud,
B.O.Villoutreix,
and
B.Parfait
(2005).
Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
|
| |
Proteins, 58,
7.
|
 |
|
|
|
|
 |
C.C.Stebbins,
C.Watzl,
D.D.Billadeau,
P.J.Leibson,
D.N.Burshtyn,
and
E.O.Long
(2003).
Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.
|
| |
Mol Cell Biol, 23,
6291-6299.
|
 |
|
|
|
|
 |
P.Chu,
J.Pardo,
H.Zhao,
C.C.Li,
E.Pali,
M.M.Shen,
K.Qu,
S.X.Yu,
B.C.Huang,
P.Yu,
E.S.Masuda,
S.M.Molineaux,
F.Kolbinger,
G.Aversa,
J.de Vries,
D.G.Payan,
and
X.C.Liao
(2003).
Systematic identification of regulatory proteins critical for T-cell activation.
|
| |
J Biol, 2,
21.
|
 |
|
|
|
|
 |
A.K.Mishra,
A.Zhang,
T.Niu,
J.Yang,
X.Liang,
Z.J.Zhao,
and
G.W.Zhou
(2002).
Substrate specificity of protein tyrosine phosphatase: differential behavior of SHP-1 and SHP-2 towards signal regulation protein SIRPalpha1.
|
| |
J Cell Biochem, 84,
840-846.
|
 |
|
|
|
|
 |
J.N.Andersen,
O.H.Mortensen,
G.H.Peters,
P.G.Drake,
L.F.Iversen,
O.H.Olsen,
P.G.Jansen,
H.S.Andersen,
N.K.Tonks,
and
N.P.Møller
(2001).
Structural and evolutionary relationships among protein tyrosine phosphatase domains.
|
| |
Mol Cell Biol, 21,
7117-7136.
|
 |
|
|
|
|
 |
J.Yang,
T.Niu,
A.Zhang,
A.K.Mishra,
Z.J.Zhao,
and
G.W.Zhou
(2001).
Relation between the flexibility of the WPD loop and the activity of the catalytic domain of protein tyrosine phosphatase SHP-1.
|
| |
J Cell Biochem, 84,
47-55.
|
 |
|
|
|
|
 |
J.Yang,
Z.Cheng,
T.Niu,
X.Liang,
Z.J.Zhao,
and
G.W.Zhou
(2001).
Protein tyrosine phosphatase SHP-1 specifically recognizes C-terminal residues of its substrates via helix alpha0.
|
| |
J Cell Biochem, 83,
14-20.
|
 |
|
|
|
|
 |
N.K.Tonks,
and
B.G.Neel
(2001).
Combinatorial control of the specificity of protein tyrosine phosphatases.
|
| |
Curr Opin Cell Biol, 13,
182-195.
|
 |
|
|
|
|
 |
Z.Y.Zhang
(2001).
Protein tyrosine phosphatases: prospects for therapeutics.
|
| |
Curr Opin Chem Biol, 5,
416-423.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|